Paediatric microbial keratitis prognosis more effective with intensive drug therapy

Article

Early diagnosis, intensive drug therapy, and timely surgical intervention are all associated with the improved prognosis of paediatric microbial keratitis.

Early diagnosis, intensive drug therapy, and timely surgical intervention are all associated with the improved prognosis of paediatric microbial keratitis, states an investigation in the European Journal of Ophthalmology.

Dr Xiusheng Song et al., Department of Ophthalmology, Renmin Hospital of Wuhan University, China, studied the medical records of 80 eyes of 76 children with non-viral microbial keratitis. The outcome measures included demographic features, predisposing factors, clinical features, etiologic microorganisms, and treatment outcomes.

Of the patients studied, 76 met the inclusion criteria. It was found that the most common predisposing factor of microbial keratitis was trauma, with 39 of 80 patients presenting as culture positive. In 21 cases bacterial isolates were found and fungi was found in 19 cases.

Out of the 58 examined eyes, 50 presented with a best-corrected visual acuity of 20/200 or better at the last follow-up. The most frequent bacteria that were isolated were coagulase-negative Staphylococcus.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.